KVUE – Kenvue Inc
KVUE — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.58
Margin Of Safety %
-17
Put/Call OI Ratio
0.34
EPS Next Q Diff
-0.02
EPS Last/This Y
0.43
EPS This/Next Y
0.05
Price
19.09
Target Price
19.3
Analyst Recom
2.8
Performance Q
8.96
Upside
-42.8%
Beta
0.38
Ticker: KVUE
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-06-02 | KVUE | 17.34 | 0.33 | 0.24 | 301478 |
| 2026-06-03 | KVUE | 16.84 | 0.33 | 0.98 | 301946 |
| 2026-06-04 | KVUE | 16.88 | 0.33 | 0.89 | 302997 |
| 2026-06-05 | KVUE | 17.72 | 0.33 | 0.02 | 303047 |
| 2026-06-08 | KVUE | 17.55 | 0.34 | 2.92 | 299699 |
| 2026-06-09 | KVUE | 17.91 | 0.35 | 0.41 | 302422 |
| 2026-06-10 | KVUE | 18.05 | 0.35 | 0.38 | 303531 |
| 2026-06-11 | KVUE | 18.08 | 0.35 | 0.10 | 303891 |
| 2026-06-12 | KVUE | 18.13 | 0.35 | 0.05 | 304030 |
| 2026-06-15 | KVUE | 18.25 | 0.33 | 0.22 | 298805 |
| 2026-06-16 | KVUE | 18.45 | 0.33 | 0.15 | 299729 |
| 2026-06-17 | KVUE | 18.02 | 0.33 | 1.80 | 300247 |
| 2026-06-18 | KVUE | 18.13 | 0.34 | 0.21 | 301616 |
| 2026-06-22 | KVUE | 17.87 | 0.34 | 2.60 | 190200 |
| 2026-06-23 | KVUE | 18.4 | 0.35 | 1.43 | 192789 |
| 2026-06-24 | KVUE | 18.8 | 0.35 | 0.82 | 194114 |
| 2026-06-25 | KVUE | 18.96 | 0.35 | 0.26 | 194950 |
| 2026-06-26 | KVUE | 18.97 | 0.35 | 0.51 | 196120 |
| 2026-06-29 | KVUE | 19.09 | 0.34 | 0.50 | 193301 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-06-01 | KVUE | 17.36 | 9.7 | 332.1 | 1.19 |
| 2026-06-02 | KVUE | 17.33 | 9.7 | 316.8 | 1.19 |
| 2026-06-03 | KVUE | 16.84 | 9.7 | 255.0 | 1.19 |
| 2026-06-04 | KVUE | 16.89 | 9.7 | 326.7 | 1.19 |
| 2026-06-05 | KVUE | 17.71 | 9.7 | 468.8 | 1.19 |
| 2026-06-08 | KVUE | 17.56 | 9.7 | 299.8 | 1.19 |
| 2026-06-09 | KVUE | 17.91 | 9.7 | 370.4 | 1.19 |
| 2026-06-10 | KVUE | 18.05 | 9.7 | 338.5 | 1.19 |
| 2026-06-11 | KVUE | 18.07 | 9.7 | 323.7 | 1.19 |
| 2026-06-12 | KVUE | 18.12 | 9.7 | 328.3 | 1.19 |
| 2026-06-15 | KVUE | 18.25 | 9.7 | 335.6 | 1.19 |
| 2026-06-16 | KVUE | 18.45 | 9.7 | 347.6 | 1.19 |
| 2026-06-17 | KVUE | 18.02 | 9.7 | 266.8 | 1.19 |
| 2026-06-18 | KVUE | 18.14 | 9.7 | 337.8 | 1.19 |
| 2026-06-22 | KVUE | 17.87 | 9.7 | 287.5 | 1.19 |
| 2026-06-23 | KVUE | 18.41 | 9.7 | 395.4 | 1.19 |
| 2026-06-24 | KVUE | 18.80 | 9.7 | 371.8 | 1.19 |
| 2026-06-25 | KVUE | 18.95 | 9.7 | 341.0 | 1.19 |
| 2026-06-26 | KVUE | 19.12 | 9.7 | 341.6 | 1.19 |
| 2026-06-29 | KVUE | 19.09 | 9.7 | 315.8 | 1.19 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-06-02 | KVUE | 235.83 | -2.17 | 3.20 |
| 2026-06-03 | KVUE | 235.83 | -2.17 | 3.20 |
| 2026-06-04 | KVUE | 235.83 | -2.17 | 3.20 |
| 2026-06-05 | KVUE | 235.83 | -2.17 | 3.20 |
| 2026-06-08 | KVUE | 235.83 | -2.25 | 3.20 |
| 2026-06-09 | KVUE | 235.83 | -2.25 | 3.20 |
| 2026-06-10 | KVUE | 235.83 | -2.25 | 3.64 |
| 2026-06-11 | KVUE | 235.83 | -2.25 | 3.64 |
| 2026-06-12 | KVUE | 235.83 | -2.25 | 3.64 |
| 2026-06-15 | KVUE | 235.69 | -2.28 | 3.64 |
| 2026-06-16 | KVUE | -1.55 | -2.28 | 3.64 |
| 2026-06-17 | KVUE | -1.55 | -2.28 | 3.64 |
| 2026-06-18 | KVUE | -1.55 | -2.28 | 3.64 |
| 2026-06-22 | KVUE | -1.55 | -2.28 | 3.64 |
| 2026-06-23 | KVUE | -1.55 | -2.28 | 3.64 |
| 2026-06-24 | KVUE | -0.61 | -2.28 | 3.64 |
| 2026-06-25 | KVUE | -0.61 | -2.28 | 3.64 |
| 2026-06-26 | KVUE | -1.55 | -2.28 | 3.58 |
| 2026-06-29 | KVUE | -1.55 | -2.28 | 3.58 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.32
Avg. EPS Est. Current Quarter
0.32
Avg. EPS Est. Next Quarter
0.3
Insider Transactions
-1.55
Institutional Transactions
-2.28
Beta
0.38
Average Sales Estimate Current Quarter
3967
Average Sales Estimate Next Quarter
3886
Fair Value
15.76
Quality Score
85
Growth Score
52
Sentiment Score
70
Actual DrawDown %
31.3
Max Drawdown 5-Year %
Target Price
19.3
P/E
22.64
Forward P/E
15.18
PEG
2.1
P/S
2.4
P/B
3.46
P/Free Cash Flow
20.11
EPS
0.84
Average EPS Est. Cur. Y
1.19
EPS Next Y. (Est.)
1.24
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.61
Relative Volume
1.04
Return on Equity vs Sector %
-10.3
Return on Equity vs Industry %
-10.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
315.8
◆
KVUE
Consumer Defensive
$19.09
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
68.3
Range 1M
99%
Sup Dist
0.6%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
10.6%
EPS NY
5.3%
52W%
58%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-12.8% upside
Upside
-12.8%
Quality
85
MoS
-17%
KVUE — P/E HistoricalHousehold & Personal Products
Kenvue Inc.Sector: Consumer Defensive
Industry: Household & Personal Products
Employees: 21780
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
KVUE
Latest News
—
Caricamento notizie per KVUE…
stock quote shares KVUE – Kenvue Inc Stock Price stock today
news today KVUE – Kenvue Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch KVUE – Kenvue Inc yahoo finance google finance
stock history KVUE – Kenvue Inc invest stock market
stock prices KVUE premarket after hours
ticker KVUE fair value insiders trading